Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14


Quantification of HER family receptors in breast cancer.

Nuciforo P, Radosevic-Robin N, Ng T, Scaltriti M.

Breast Cancer Res. 2015 Apr 9;17:53. doi: 10.1186/s13058-015-0561-8. Review.


Genomic profiling in luminal breast cancer.

Gluz O, Hofmann D, W├╝rstlein R, Liedtke C, Nitz U, Harbeck N.

Breast Care (Basel). 2013 Dec;8(6):414-22. doi: 10.1159/000357535. Review.


Comparability and reproducibility of biomedical data.

Huang Y, Gottardo R.

Brief Bioinform. 2013 Jul;14(4):391-401. doi: 10.1093/bib/bbs078. Epub 2012 Nov 27. Review.


Influence of RNA labeling on expression profiling of microRNAs.

Kaddis JS, Wai DH, Bowers J, Hartmann N, Baeriswyl L, Bajaj S, Anderson MJ, Getts RC, Triche TJ.

J Mol Diagn. 2012 Jan;14(1):12-21. doi: 10.1016/j.jmoldx.2011.08.005. Epub 2011 Nov 7.


Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer Assay.

Clark-Langone KM, Sangli C, Krishnakumar J, Watson D.

BMC Cancer. 2010 Dec 23;10:691. doi: 10.1186/1471-2407-10-691.


Evaluation of external RNA controls for the standardisation of gene expression biomarker measurements.

Devonshire AS, Elaswarapu R, Foy CA.

BMC Genomics. 2010 Nov 24;11:662. doi: 10.1186/1471-2164-11-662.


Can survival prediction be improved by merging gene expression data sets?

Yasrebi H, Sperisen P, Praz V, Bucher P.

PLoS One. 2009 Oct 23;4(10):e7431. doi: 10.1371/journal.pone.0007431.


Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer.

Oakman C, Bessi S, Zafarana E, Galardi F, Biganzoli L, Di Leo A.

Breast Cancer Res. 2009;11(2):205. doi: 10.1186/bcr2238. Epub 2009 Apr 3. Review.


Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purification.

Smith MJ, Culhane AC, Donovan M, Coffey JC, Barry BD, Kelly MA, Higgins DG, Wang JH, Kirwan WO, Cotter TG, Redmond HP.

Br J Cancer. 2009 May 5;100(9):1452-64. doi: 10.1038/sj.bjc.6604931.


The MINDACT trial: the first prospective clinical validation of a genomic tool.

Cardoso F, Piccart-Gebhart M, Van't Veer L, Rutgers E; TRANSBIG Consortium.

Mol Oncol. 2007 Dec;1(3):246-51. doi: 10.1016/j.molonc.2007.10.004. Epub 2007 Oct 22.


Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2009 Jan;11(1):66-73. doi: 10.1097/GIM.0b013e3181928f56.


The Sterolgene v0 cDNA microarray: a systemic approach to studies of cholesterol homeostasis and drug metabolism.

Rezen T, Juvan P, Fon Tacer K, Kuzman D, Roth A, Pompon D, Aggerbeck LP, Meyer UA, Rozman D.

BMC Genomics. 2008 Feb 11;9:76. doi: 10.1186/1471-2164-9-76.


Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers.

Dumur CI, Lyons-Weiler M, Sciulli C, Garrett CT, Schrijver I, Holley TK, Rodriguez-Paris J, Pollack JR, Zehnder JL, Price M, Hagenkord JM, Rigl CT, Buturovic LJ, Anderson GG, Monzon FA.

J Mol Diagn. 2008 Jan;10(1):67-77. Epub 2007 Dec 13.

Supplemental Content

Support Center